MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$2,920K
Free Cash flow
-$1,998K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from the issuance of co...
Proceeds from tranche financing
Proceeds from issuance of notes ...
Others
Negative Cash Flow Breakdown
Repurchase of series x preferred...
Change in fair value of warrant ...
Payments of note payable to rela...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2025-09-30
2025-06-30
Stock-based compensation
-
0
Net loss
510
-5,843
Depreciation and amortization
257
382
Noncash interest expense
68
134
Change in fair value of warrant liability
3,203
1,410
Issuance cost allocated to warrant liability
332
1,088
Trade receivable
137
-15
Other accounts receivable and prepaid expenses
29
216
Inventory
37
-380
Trade payables
221
99
Other accounts payable and accrued expenses
27
656
Deferred revenue
0
-15
Operating lease liabilities, net
-3
1
Accrued severance pay, net
24
3
Net cash used in operating activities
-1,970
-4,726
Cash acquired in envue merger
0
148
Purchase of property and equipment
28
9
Net cash used in investing activities
-28
139
Proceeds from the issuance of commons stock, preferred stock and warrants, net
8,920
8,215
Repurchase of series x preferred stock
5,000
-
Proceeds from tranche financing
2,000
-
Proceeds from issuance of notes payable to a related party
1,300
-
Payments of note payable to related party
1,300
-
Payments of short-term loan to related party
1,000
777
Proceeds from issuance of convertible note payable from related party
-
1,300
Proceeds from issuance of short-term loan payable
0
360
Payments of note payable to related party
-
1,300
Proceeds from exercise of options and warrants
0
102
Net cash provided by financing activities
4,920
7,900
Effects of currency translation on cash and cash equivalents
-2
-5
Net increase in cash, cash equivalents and restricted cash
2,920
3,308
Cash and cash equivalents at beginning of period
752
-
Cash and cash equivalents at end of period
6,980
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from the
issuance of commons...
$8,920K
Proceeds from tranche
financing
$2,000K
Proceeds from issuance of
notes payable to a...
$1,300K
Net cash provided by
financing activities
$4,920K
Canceled cashflow
$7,300K
Net increase in
cash, cash...
$2,920K
Canceled cashflow
$2,000K
Repurchase of series x
preferred stock
$5,000K
Payments of note payable
to related party
$1,300K
Payments of short-term
loan to related party
$1,000K
Net loss
$510K
Issuance cost allocated
to warrant...
$332K
Depreciation and
amortization
$257K
Trade payables
$221K
Noncash interest
expense
$68K
Other accounts
payable and accrued...
$27K
Accrued severance pay,
net
$24K
Net cash used in
operating activities
-$1,970K
Net cash used in
investing activities
-$28K
Effects of currency
translation on cash and cash...
-$2K
Canceled cashflow
$1,439K
Change in fair value of
warrant liability
$3,203K
Purchase of property and
equipment
$28K
Trade receivable
$137K
Inventory
$37K
Other accounts
receivable and prepaid...
$29K
Operating lease
liabilities, net
-$3K
Buy us a coffee
NanoVibronix, Inc. (NAOV)
NanoVibronix, Inc. (NAOV)